Work

Chemical biology and pharmacology of histone lysine methylation inhibitors

Year: 2022

Type: review

Source: Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms

DOI: 10.1016/j.bbagrm.2022.194840

Authors: Samir H. Barghout, Raquel Arminda Carvalho Machado, Dalia Barsyte-Lovejoy

Institutions: University of Toronto, Tanta University, Structural Genomics Consortium

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, McGill University, Genome Canada, Merck KGaA, Ontario Genomics Institute, Kungliga Tekniska Högskolan, Mitacs, Innovative Medicines Initiative, Genentech, Takeda Canada, Natural Sciences and Engineering Research Council of Canada, Janssen Pharmaceuticals

Awards: G1822068471, G2003881057, G4670266517

OpenAlex ID: W4283375792

FWCI: 0.681

Cites: 359

Cited by: 29

Related to: 10